Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19

Summary

This is open-labe randomized multicenter comparative Phase III study conducted in 5 medical facilities. The objective of the study is to assess the efficacy and safety of Favipiravir compared with the Standard of care (SOC) in hospitalized patients with moderate COVID-19 pneumonia.

Timeline

Start

2020-05-21

Primary completion

2020-08-10

Completion

2020-08-20

Drugs

Indications